Advertisement

Topic: Daniel Schultz

Jump to

Latest Headlines Quotes

Science News // 1 decade ago

FDA OK's arterial plaque imaging device

The U.S. Food and Drug Administration said it has approved a device that can see inside a blood vessel to assess the fat content of the arterial plaque.

Science News // 1 decade ago

FDA approves new respiratory virus test

The U.S. Food and Drug Administration has approved a test that detects four respiratory viruses, including the flu, in a patient's respiratory secretions.

Science News // 1 decade ago

New genetic breast cancer test is approved

The U.S. Food and Drug Administration has approved a test that helps assess the risk of tumor recurrence in high-risk breast cancer patients.

Science News // 1 decade ago

Company warns of heart device malfunctions

Implanted heart device manufacturer Medtronic of Minneapolis is asking doctors to discontinue use of a component in its newest defibrillator models.

Science News // 1 decade ago

FDA OKs warfarin sensitivity lab test

The U.S. Food and Drug Administration has approved a genetic test that determines a patient's sensitivity to the "blood-thinning" drug warfarin.

Science News // 1 decade ago

FDA approves cervical disk device

The U.S. Food and Drug Administration Tuesday announced approval of the first device designed to treat cervical degenerative disc disease.

Science News // 1 decade ago

FDA approves new breast cancer lab test

The U.S. Food and Drug Administration has approved the first molecular-based laboratory test for detecting whether breast cancer has metastasized.

Science News // 1 decade ago

FDA approves emergency face masks

The U.S. Food and Drug Administration has approved the first face masks designed for public use in a medical emergency, such as an influenza pandemic.

Science News // 1 decade ago

FDA wants Shelhigh medical device recall

The U.S. Food and Drug Administration has formally asked Shelhigh Inc. to recall all its medical devices because of sterility concerns.

Science News // 1 decade ago

FDA approves DNA suture technology

The U.S. Food and Drug Administration approved the use of sutures made from material isolated from bacteria modified by recombinant DNA technology.

Quotes

Designing and testing medical devices for children is challenging because they are still growing
FDA OKs kids' cardiac adhesion barrier Mar 09, 2009

The extensive body of scientific evidence provides reasonable assurance of the benefits and risks of these devices
FDA approves silicone breast implants Nov 17, 2006

This test represents a significant advance in the application of genetic technology and paves the way for similar genetic diagnostic tests to be developed in the future
FDA OKs CF detection kit May 10, 2005

(Georg) Daniel Schultz the Younger (1615–1683) was a famous painter of the Baroque era. Born probably around 1615 in Danzig (Gdańsk), he painted many local Patricians, such as the astronomer Johannes Hevelius, as well as animals.

Schultz learned the art of painting from his uncle, Daniel Schultz the Elder (died 1646), another important painter, working in his workshop for about five years. After his uncle's death he went to France and the Netherlands to continue his studies for about three years.

He became the leading artist at the Warsaw court of the Polish kings in the second half of the 17th century as well. In 1649 he became a private painter to the Polish king John II, and then to successor kings Michael Wiśniowiecki and John III Sobieski. Schultz returned to his hometown around 1660, yet from time to time worked on royal commissions in Warsaw, often in the Wilanów Palace. His great portraits of Polish kings and nobles are among the best examples of Baroque art in Poland.

FULL ARTICLE AT WIKIPEDIA.ORG

This article is licensed under the GNU Free Documentation License.
It uses material from the Wikipedia article "Daniel Schultz."